| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.031 | 0.5 |